Filing Details
- Accession Number:
- 0001104659-19-037410
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-25 16:16:37
- Reporting Period:
- 2019-06-21
- Accepted Time:
- 2019-06-25 16:16:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1481512 | Ra Pharmaceuticals Inc. | RARX | Pharmaceutical Preparations (2834) | 262908274 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1768722 | Alonso Ricardo | C/O Ra Pharmaceuticals, Inc. 87 Cambridgepark Drive Cambridge MA 02140 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-06-21 | 2,857 | $23.72 | 11,428 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2019.
- The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.385 to $24.12. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
